Xenon Pharmaceuticals
XENE
XENE
66 hedge funds and large institutions have $245M invested in Xenon Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9.87% more ownership
Funds ownership: 62.44% → 72.3% (+9.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
66
Holding in Top 10
2
Calls
$253K
Puts
–
Top Buyers
| 1 | +$6.57M | |
| 2 | +$4.1M | |
| 3 | +$2.26M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.26M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$2.18M |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$861K | |
| 3 | -$728K | |
| 4 |
Squarepoint
New York
|
-$579K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$463K |